Machine learning for adverse event prediction in outpatient parenteral antimicrobial therapy: a scoping review

被引:0
|
作者
Challener, Douglas W. [1 ]
Fida, Madiha [1 ]
Martin, Peter [2 ]
Rivera, Christina G. [3 ]
Virk, Abinash [1 ]
Walker, Lorne W. [4 ,5 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA
[3] Mayo Clin, Dept Pharm, Rochester, MN USA
[4] Oregon Hlth & Sci Univ, Div Pediat Infect Dis, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA
关键词
ANTIBIOTIC-THERAPY; RISK-FACTORS; HEALTH-CARE; VANCOMYCIN; INFUSION; READMISSIONS; DAPTOMYCIN; MODEL; OPAT;
D O I
10.1093/jac/dkae340
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective This study aimed to conduct a scoping review of machine learning (ML) techniques in outpatient parenteral antimicrobial therapy (OPAT) for predicting adverse outcomes and to evaluate their validation, implementation and potential barriers to adoption.Materials and methods This scoping review included studies applying ML algorithms to adult OPAT patients, covering techniques from logistic regression to neural networks. Outcomes considered were medication intolerance, toxicity, catheter complications, hospital readmission and patient deterioration. A comprehensive search was conducted across databases including Cochrane Central, Cochrane Reviews, Embase, Ovid MEDLINE and Scopus, from 1 January 2000 to 1 January 2024.Results Thirty-two studies met the inclusion criteria, with the majority being single-centre experiences primarily from North America. Most studies focused on developing new ML models to predict outcomes such as hospital readmissions and medication-related complications. However, there was very little reporting on the performance characteristics of these models, such as specificity, sensitivity and C-statistics. There was a lack of multi-centre or cross-centre validation, limiting generalizability. Few studies advanced beyond traditional logistic regression models, and integration into clinical practice remains limited.Discussion ML shows promise for enhancing OPAT outcomes by predicting adverse events and enabling pre-emptive interventions. Despite this potential, significant gaps exist in development, validation and practical implementation. Barriers include the need for representative data sets and broadly applicable, validated models.Conclusion Future research should address these barriers to fully leverage ML's potential in optimizing OPAT care and patient safety. Models must deliver timely, accurate and actionable insights to improve adverse event prediction and prevention in OPAT settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review
    Carter, Bernie
    Carrol, Enitan D.
    Porter, David
    Peak, Matthew
    Taylor-Robinson, David
    Fisher-Smith, Debra
    Blake, Lucy
    BMJ OPEN, 2018, 8 (11):
  • [2] Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
    Duncan, Christopher J. A.
    Barr, David A.
    Seaton, R. Andrew
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (03) : 410 - 417
  • [3] Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
    Christopher J. A. Duncan
    David A. Barr
    R. Andrew Seaton
    International Journal of Clinical Pharmacy, 2012, 34 : 410 - 417
  • [4] Outpatient parenteral antimicrobial therapy with carbapenems: A systematic review
    Wolie, Z. T.
    Roberts, J. A.
    Wale, Y. M.
    Unwin, S.
    McCarthy, K.
    Sime, F. B.
    JOURNAL OF INFECTION, 2024, 89 (05)
  • [5] Outpatient parenteral antimicrobial therapy
    Chapman, Ann L. N.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [6] Outpatient parenteral antimicrobial therapy
    Bellamy, Richard
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (01) : 12 - 17
  • [7] Outpatient Parenteral Antimicrobial Therapy
    Bowling, Jason E.
    Lewis, James S., II
    Owens, Aaron D.
    HOSPITAL MEDICINE CLINICS, 2013, 2 (01) : E45 - E56
  • [8] Outpatient parenteral antimicrobial therapy
    Laupland, Kevin B.
    Valiquette, Louis
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (01): : 9 - 11
  • [9] Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review
    Psaltikidis, Eliane Molina
    da Silva, Everton Nunes
    Bustorff-Silva, Joaquim Murray
    Moretti, Maria Luiza
    Resende, Mariangela Ribeiro
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (04) : 355 - 375
  • [10] Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy
    Keller, Sara C.
    Williams, Deborah
    Gavgani, Mitra
    Hirsch, David
    Adamovich, John
    Hohl, Dawn
    Gurses, Ayse P.
    Cosgrove, Sara E.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (01) : 11 - 19